We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-1.58%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.06%
5 Year Est. Return
+670.57%
10 Year Est. Return
–
AUM
$1.43B
AUM Growth
+$223M
Cap. Flow
+$517M
Cap. Flow %
36.15%
Top 10 Hldgs %
41.55%
Holding
794
New
212
Increased
219
Reduced
129
Closed
151

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$169M
2
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$48.6M
3
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
+$29.1M
4
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$22.5M
5
SIRI icon
SiriusXM
SIRI
+$20.3M

Top Sells

Rank Stock Value
1
MMP
Magellan Midstream Partners, L.P.
MMP
+$45.2M
2
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$24.1M
3
EOCW
Elliott Opportunity II Corp.
EOCW
+$15.2M
4
DNAD
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
+$11.4M
5
BWC
Blue Whale Acquisition Corp I Class A Ordinary Shares
BWC
+$8.23M

Sector Composition

Rank Sector Weight
1 Financials 29.55%
2 Technology 21.97%
3 Healthcare 21.97%
4 Communication Services 4.12%
5 Industrials 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.86T
$248M 17.37%
5,707,210
+3,779,710
+196% +$169M
ESTA icon
2
Establishment Labs
ESTA
$2.72B
$56M 3.92%
1,141,172
+175,000
+18% +$10.5M
XLE icon
3
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$50.2M 3.52%
+1,111,604
New +$48.6M
MSOS icon
4
AdvisorShares Pure US Cannabis ETF
MSOS
$858M
$48.7M 3.41%
6,139,280
+3,573,000
+139% +$22.5M
AAC
5
DELISTED
Ares Acquisition Corporation
AAC
$36.4M 2.55%
3,385,401
+553,775
+20% +$5.9M
RNAM
6
DELISTED
Avidity Biosciences
RNAM
$35.9M 2.51%
5,629,103
– –
TARS icon
7
Tarsus Pharmaceuticals
TARS
$2.58B
$31.9M 2.23%
1,796,773
-202,610
-10% -$3.59M
CVII
8
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$29.3M 2.05%
+2,800,465
New +$29.1M
SIRI icon
9
SiriusXM
SIRI
$9.97B
$28.8M 2.02%
637,600
+437,600
+219% +$20.3M
MERC icon
10
Mercer International
MERC
$42.3M
$28.3M 1.98%
3,300,000
+1,900,000
+136% +$16.4M
PTGX icon
11
Protagonist Therapeutics
PTGX
$8.79B
$27.6M 1.93%
1,657,551
– –
AVDL
12
DELISTED
Avadel Pharmaceuticals
AVDL
$24.1M 1.69%
2,338,302
-325,774
-12% -$4.36M
IMCR icon
13
Immunocore
IMCR
$1.72B
$23.9M 1.67%
460,036
– –
META icon
14
Meta Platforms (Facebook)
META
$1.42T
$22.7M 1.58%
75,453
+32,911
+77% +$9.92M
RCKT icon
15
Rocket Pharmaceuticals
RCKT
$340M
$22.5M 1.58%
1,100,000
– –
SLAM
16
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$20.1M 1.4%
1,860,843
+909,440
+96% +$9.77M
FULC icon
17
Fulcrum Therapeutics
FULC
$239M
$19.1M 1.34%
4,308,359
+1,191,363
+38% +$5.21M
RRAC
18
DELISTED
Rigel Resource Acquisition Corp.
RRAC
$18.9M 1.32%
1,731,483
+184,349
+12% +$1.99M
ET icon
19
Energy Transfer Partners
ET
$70.1B
$18.3M 1.28%
1,305,000
-130,000
-9% -$1.72M
PTCT icon
20
PTC Therapeutics
PTCT
$5.64B
$17.9M 1.25%
799,511
– –
HCVIU
21
DELISTED
Hennessy Capital Investment Corp. VI Unit
HCVIU
$17.4M 1.22%
1,501,275
+1,275
+0.1% +$13.2K
NETD
22
DELISTED
Nabors Energy Transition Corp II
NETD
$17.1M 1.19%
+1,677,458
New +$17.1M
PEGR
23
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$17M 1.19%
1,624,118
-185,496
-10% -$1.93M
TRTL
24
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
$15.5M 1.08%
1,474,505
+841,293
+133% +$8.79M
STOK icon
25
Stoke Therapeutics
STOK
$1.8B
$14.7M 1.03%
3,721,659
– –
1
2 3 4 5

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2023 Portfolio in Review

As of Q3 2023, Cowen and Company held 794 positions worth $1.43B, up 18% from $1.21B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Cowen and Company deployed $517M of net new capital in Q3 2023, opening 212 new positions and adding to 219 existing holdings. Its largest new stake was State Street Energy Select Sector SPDR ETF: 1,111,604 shares worth $50.2M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Kensington Capital Acquisition Corp. V, an estimated $7.13M trimmed.

  • Cowen and Company's largest Q3 2023 buy was State Street Energy Select Sector SPDR ETF: 1,111,604 shares worth $50.2M.
  • Cowen and Company added most to NVIDIA in Q3 2023, an estimated $169M increase.
  • Cowen and Company's biggest Q3 2023 reduction was Kensington Capital Acquisition Corp. V, cutting an estimated $7.13M.
  • Cowen and Company fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.2M.
  • Cowen and Company's ten largest holdings make up 42% of its $1.43B portfolio in Q3 2023.
  • Cowen and Company opened 212 new positions and closed 151 in Q3 2023.
  • Cowen and Company's portfolio value rose 18% quarter-over-quarter to $1.43B.

Based on Cowen and Company's 13F filing for Q3 2023, filed 9 Nov 2023.